ALMS
Alumis Inc
NASDAQ: ALMS · HEALTHCARE · BIOTECHNOLOGY
$24.69
+7.86% today
Updated 2026-04-30
Market cap
$2.91B
P/E ratio
—
P/S ratio
121.06x
EPS (TTM)
$-2.86
Dividend yield
—
52W range
$3 – $31
Volume
1.5M
Alumis Inc (ALMS) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $24.05M |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | $250000.00 | $1.28M | $3.15M | $3.50M |
| Gross profit | $-250000.00 | $-1.28M | $-3.15M | $20.55M |
| Gross margin | — | — | — | 85.5% |
| R&D | $101.05M | $137.68M | $265.55M | $386.00M |
| SG&A | $12.55M | $20.50M | $35.20M | $91.86M |
| Operating income | $-113.85M | $-158.17M | $-300.75M | $-427.20M |
| Operating margin | — | — | — | -1776.3% |
| EBITDA | $-113.60M | $-156.89M | $-297.60M | $-423.71M |
| EBITDA margin | — | — | — | -1761.8% |
| EBIT | $-113.85M | $-158.17M | $-300.75M | $-427.20M |
| Interest expense | — | — | — | — |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-111.93M | $-154.99M | $-294.23M | $-243.32M |
| Net income growth (YoY) | — | -38.5% | -89.8% | +17.3% |
| Profit margin | — | — | — | -1011.7% |